Finance

Lists
PRE:NASDAQ
Prenetics Global Ltd
20,35 USD
+0,89%
(+0,18) 1D
5-окт., 09:43:37 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PRE...
Open
20,64 USD
High
20,75 USD
Low
20,10 USD
Mkt. cap
348,87 млн
Avg. vol.
256,20 миң
Volume
6,20 миң
52-wk high
27,24 USD
52-wk low
11,36 USD
EPS
-2,88 USD
Beta
0,40
Shares outstanding
15,56 млн
No. of employees
98
Open
20,64 USD
High
20,75 USD
Low
20,10 USD
Mkt. cap
348,87 млн
Avg. vol.
256,20 миң
Volume
6,20 миң
52-wk high
27,24 USD
52-wk low
11,36 USD
EPS
-2,88 USD
Beta
0,40
Shares outstanding
15,56 млн
No. of employees
98
News stories
From web sources and news partners
Profile
Prenetics is a health sciences company headquartered in Hong Kong, with a presence in the United States. It focuses on early detection, prevention, and treatment of diseases, particularly cancer. Its subsidiary brands include CircleDNA, Insighta and IM8. Wikipedia
About Prenetics Global Ltd
CEO-
Employees98
Founded2014
Headquarters-
SectorHealth care provider
Websiteprenetics.com
Analyst ratings
Based on 5 analysts giving stock ratings to PRE in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for PRE in the last 3 months.
Highest
Current 20,35 USD
40,00 USD (+96,56%)
Average
37,00 USD (+81,82%)
Lowest
35,00 USD (+71,99%)
Analyst
Recommendation
Action
Price target
Projected
Date
Eric Des Lauriers
Craig-Hallum
Buy
Maintained
-
-
09/22/2026
Unknown Analyst
StoneX
Buy
Reiterated
40,00 USD
+96,6%
09/08/2026
Jeff Van Sinderen
B. Riley Securities
Buy
Initiated
37,00 USD
+81,8%
08/27/2026
Ryan Meyers
Lake Street
Buy
Reiterated
35,00 USD
+72%
08/19/2026
George Kelly
Roth MKM
Buy
Maintained
36,00 USD
+76,9%
08/19/2026
Bill Sutherland
Benchmark Co.
Buy
Maintained
40,00 USD
+96,6%
07/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
23,56 млн
36,56 млн
35,95 млн
46,49 млн
Cost of goods sold
9,53 млн
14,97 млн
12,67 млн
16,28 млн
Cost of revenue
9,53 млн
14,97 млн
12,67 млн
16,28 млн
Research and development expenses
1,17 млн
743,00 миң
1,44 млн
757,00 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19,41 млн
34,13 млн
31,55 млн
51,36 млн
Operating expense
20,19 млн
35,17 млн
32,15 млн
51,18 млн
Total operating expenses
29,72 млн
50,14 млн
44,82 млн
67,47 млн
Operating income
-6,16 млн
-13,58 млн
-8,87 млн
-20,98 млн
Other non operating income
96,00 миң
9,59 млн
-17,86 млн
9,28 млн
EBT including unusual items
-6,78 млн
-9,66 млн
-27,31 млн
-9,08 млн
EBT excluding unusual items
-6,78 млн
-3,87 млн
-26,74 млн
-11,71 млн
Income tax expense
9,00 миң
38,00 миң
28,00 миң
5,00 миң
Effective tax rate
-0,13%
-0,39%
-0,10%
-0,06%
Other operating expenses
-395,00 миң
297,00 миң
-840,00 миң
-941,00 миң
Net income
-7,41 млн
-7,50 млн
-23,10 млн
-8,98 млн
Net profit margin
-31,45%
-20,52%
-64,26%
-19,32%
Earnings per share
-
-0,19
-
-0,52
Interest and investment income
-
1,20 млн
-
-
Interest expense
-55,00 миң
-45,00 миң
-9,00 миң
-13,00 миң
Net interest expenses
-55,00 миң
1,15 млн
-9,00 миң
-13,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-5,33 млн
-13,34 млн
-8,71 млн
-20,80 млн
Gain or loss from assets sale
-
-
-253,00 миң
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору